首页> 外文会议>International Symposium on Atherosclerosis >Fatty acids, cholesterol, and sphingolipids: interactive regulators and targets for SREBP processing
【24h】

Fatty acids, cholesterol, and sphingolipids: interactive regulators and targets for SREBP processing

机译:脂肪酸,胆固醇和鞘脂:互动调节剂和Srebp加工的目标

获取原文

摘要

Sterol regulatory element-binding protein (SREBPs) have a major role in regulating transcription of many genes involved in lipid biology and pathobiology.In addition to inhibitory effects of cholesterol on cleavage of the precursor of SREBP (pSREBP) to the active mature nuclear form (mSREBP), polyunsaturated fatty acids (PUFA)-but not saturated fatty acids-have a key role in inhibiting formation of the active mSREBP.The ability of PUFA to decrease SREBP-dependent gene transcription is related in part to effects on modulating intracellular cholesterol partitioning and through effects on sphingolipid metabolism Effects related to sphingolipids are due in part to their higher affinity for free cholesterol, as well as to the ability of PUFA to increase cell sphingomyelinase activity leading to production of ceramide. The inhibitory effects of ceramide on SREBP cleavage are associated with the ability of ceramide to inhibit its own de novo intracellular synthesis, which we hypothesize effects normal SREBP trafficking between the endoplasmic reticulum (ER) and Golgi compartments.Our work indicates that intermediates of sphingomyelin metabolism now join cholesterol and fatty acids as important regulators of SREBP processing, and offer new therapeutic targets for disorders of lipid metabolism including dyslipidemias, steatohepatitis, obesity, and type II diabetes.
机译:甾醇调节元素结合蛋白(Srebps)在调节脂质生物学和病理学和病理学的许多基因的转录中具有重要作用。除了胆固醇对胆固醇的抑制作用对Srebp(Psrebp)前体的裂解至活性成熟核形式( Msrebp),多不饱和脂肪酸(PUFA) - 但不是饱和脂肪酸 - 对抑制活性MSREBP的形成具有关键作用。PUFA降低Srebp依赖性基因转录的能力是有关调节细胞内胆固醇分配的影响有关通过对与鞘磷脂相关的鞘脂代谢效应的影响部分是对游离胆固醇的更高的亲和力,以及PUFA增加细胞鞘氨基酶活性导致神经酰胺的能力。神经酰胺对Srebp切割的抑制作用与神经酰胺抑制其自身的细胞内合成的能力相关,我们假设正常的Srebp贩运成内质网(ER)和Golgi隔间之间的影响。您的工作表明鞘鞘素代谢的中间体现在加入胆固醇和脂肪酸作为Srebp加工的重要调节因素,为脂质代谢疾病提供新的治疗目标,包括血脂血症,脱脂性肝炎,肥胖症和II型糖尿病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号